Text Size

Needs Assessment for Bereaved Families (NABF)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2007 by Herzog Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Joint Distribution Committee (JDC)
Information provided by:
Herzog Hospital
ClinicalTrials.gov Identifier:
NCT00447252
First received: March 13, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
  Purpose

The present study will focus on several objectives in the framework of the family perspective and systemic understanding of the mourning process:

  1. Identification of the psychological, social and practical needs of families that have lost a child to terrorism.
  2. Deepening and extending the knowledge of how families cope with the loss of a child in a violent incident of a security-related nature.
  3. Identification of risk and resilience factors within the family structure, and the nature of the relationships within the family.

Condition Phase
Bereaved Families
 Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Needs Assessment for Bereaved Families

Resource links provided by NLM:

MedlinePlus related topics: Bereavement
U.S. FDA Resources

Further study details as provided by Herzog Hospital:

Estimated Enrollment: 100
Study Start Date: January 2007
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   2 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • lost a son or daughter below the age of 18 as a result of a terrorist incident,
  • at least six months previously

Exclusion Criteria:

  • single-parent families
  • family members who suffer from mental retardation, disturbances because of addiction, or psychiatric disturbance from the psychotic or autistic spectra (schizophrenia, manic-depressive illness, psychotic disturbances, PDD).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00447252

Contacts
Contact: Danny Brom, Ph.d +972-2-6449666 dbrom@herzoghospital.org

Locations
Israel
The Israel Center for the Treatment of Psychotrauma Recruiting
Jerusalem, Israel
Contact: Danny Brom, Ph.D     +972-2-6449666     DBROM@HERZOGHOSPITAL.ORG    
Principal Investigator: Danny Brom, Ph.D            
Sponsors and Collaborators
Herzog Hospital
Joint Distribution Committee (JDC)
Investigators
Study Director: Danny Brom, Ph.D The Israel Center for the Treatment of Psychotrauma
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00447252     History of Changes
Other Study ID Numbers: Brom2CTIL
Study First Received: March 13, 2007
Last Updated: March 13, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by Herzog Hospital:
bereavement
grief

ClinicalTrials.gov processed this record on May 21, 2013